Other MMPIs focusing on malignancies and tested in clinical trials include neovastat, which strongly inhibits MMP2 activity (metastatic kidney cancer, advanced colorectal/breast cancer) [114] and BMS-275291, a wide-spectrum MMPI (lung, breast cancer) [109,115]. Here, MMP2 is linked to breast carcinoma.